Stock listing

Xeris Biopharma Holdings, Inc.

Selected listing: 2B30 · SWB · EUR · DE

Xeris Biopharma Holdings, Inc. (Stuttgart:2B30), Health Technology. Latest release Oct 2, 2026: Xeris Announces Inducement Grants Under NASDAQ Listing Rule…

2B30:SWBEURDEUpdated October 2, 2026

Ticker: Stuttgart:2B30
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Stuttgart
Currency: EUR

Latest news from Xeris Biopharma Holdings, Inc.

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

October 2, 2026

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

October 1, 2026

medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector

September 10, 2026

Medmix : rsquo; Drug Delivery (“Haselmeier”) to support the development of Xeris Pharmaceuticals’ XP-8121 with D-Flex™ pen injector

September 10, 2026

Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism

September 9, 2026

All Xeris Biopharma Holdings, Inc. news →

Events

Replays

Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:30 AM ET
Watch
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call
Mon, Mar 02, 2026 · 08:30 AM ET
Watch

Research Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. company profile

View the public company page for Xeris Biopharma Holdings, Inc. on 6ix.

Xeris Biopharma Holdings, Inc. news

Read company news and market updates connected to Xeris Biopharma Holdings, Inc..

Xeris Biopharma Holdings, Inc. investor events

Find investor webinars, events, and replay context for Xeris Biopharma Holdings, Inc..